Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
continuous glucose monitor
MedTech
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Dexcom said Smart Basal is the first CGM-integrated application in Type 2 diabetes for people taking a glargine U-100 long-acting insulin.
Conor Hale
Nov 19, 2025 9:45am
Walmart to sell Abbott's CGM in US 1st
Oct 21, 2025 12:40pm
FDA clears Biolinq's color-coded sensor patch for glucose ranges
Sep 29, 2025 11:30am
Dexcom CEO goes on leave while Insulet taps new CFO
Sep 17, 2025 12:15pm
Senseonics to retake Eversense commercial control from Ascensia
Sep 5, 2025 2:00pm
Medtronic debuts Abbott Instinct CGM as MiniMed 780G enters T2D
Sep 2, 2025 11:00am
